Sanmina Corporation
SANM
$192.16
+6.74%
Sanmina Corporation is a global provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers (OEMs) across the communications networks, storage, industrial, defense, and aerospace end markets. The company operates as a key contract manufacturer and electronics manufacturing services (EMS) provider, managing its operations primarily through its Integrated Manufacturing Solutions (IMS) and Components, Products, & Services (CPS) segments. The current investor narrative centers on the company's significant revenue growth, particularly in its most recent quarter, and its positioning to capitalize on demand in strategic sectors like industrial and defense, though this is juxtaposed against ongoing margin pressures inherent in the competitive EMS industry.…
SANM
Sanmina Corporation
$192.16
Investment Opinion: Should I buy SANM Today?
Rating: Hold. The core thesis is that Sanmina's explosive revenue growth is compelling, but severe margin compression and a premium trailing valuation create a balanced risk/reward profile that warrants caution. Supporting evidence includes the 58.98% YoY revenue growth in Q1 2026, robust TTM free cash flow of $518.3 million, a strong balance sheet (D/E 0.17), and an attractive forward P/E of 14.32x based on analyst EPS estimates of $12.78. However, the trailing P/E of 25.59x is above typical industrial peers, and the net margin of 1.55% is under significant pressure, down from 3.36% just two quarters prior. The thesis would upgrade to a Buy if gross margins stabilize above 8% and the forward P/E compresses further on sustained earnings growth. It would downgrade to a Sell if revenue growth decelerates sharply below 10% YoY or net margins fall below 1%. Based on the current data mix, the stock appears fairly valued to slightly overvalued relative to its near-term profitability challenges, but undervalued on a forward earnings basis if margin recovery materializes.
Sign up to view all
SANM 12-Month Price Forecast
The outlook is balanced with a slight skew to the base case. The forward valuation is reasonable if the company can deliver on the implied earnings recovery, but the severe margin deterioration in the face of massive revenue growth is a major red flag. The stock's fate hinges on the next few quarterly reports demonstrating margin stability. A stance upgrade to bullish would require clear evidence of margin expansion. A downgrade to bearish would be triggered by another quarter of margin contraction coupled with slowing growth. The high cash flow and solid balance sheet provide a margin of safety against a catastrophic bear case.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sanmina Corporation's 12-month outlook, with a consensus price target around $249.81 and implied upside of +30.0% versus the current price.
Average Target
$249.81
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$154 - $250
Analyst target range
Analyst coverage for Sanmina is limited, with data indicating only one analyst providing estimates, which constitutes insufficient coverage for a reliable consensus. The single analyst projects an average EPS of $12.78 and revenue of $16.36 billion. The lack of a broad analyst target price and recommendation distribution means there is no clear consensus upside or downside implied from the current price. This limited coverage is typical for a mid-cap industrial/technology company like Sanmina and can lead to higher volatility and less efficient price discovery. With only one analyst providing estimates, a meaningful target price range cannot be established. The available institutional ratings data shows sporadic actions, with the most recent being a 'Buy' reiteration by Argus Research in January 2026 and a series of 'Neutral' or 'Hold' ratings from other firms throughout 2024 and 2025. The wide gap in time between ratings and the minimal number of active covering analysts signals high uncertainty and a lack of sustained institutional research focus. This environment places greater onus on investors to conduct their own fundamental and technical due diligence.
Bulls vs Bears: SANM Investment Factors
The investment debate for Sanmina centers on the tension between explosive top-line growth and deteriorating profitability. The bull case is supported by a 59% YoY revenue surge, strong cash generation, and a reasonable forward P/E of 14.3x. The bear case highlights severe margin compression, revenue lumpiness, and a premium trailing valuation. Currently, the bearish evidence on margins carries significant weight, as it directly challenges the sustainability of the growth narrative. The single most important factor is whether management can stabilize and improve margins in the coming quarters. If margins recover, the growth story is compelling; if they continue to compress, the stock's elevated multiple is unjustified.
Bullish
- Explosive Revenue Growth: Q1 2026 revenue surged 58.98% YoY to $3.19 billion, driven by the Integrated Manufacturing Solutions segment. This indicates Sanmina is capturing significant demand in its core end markets like industrial and defense, providing a powerful top-line catalyst.
- Strong Cash Generation & Healthy Balance Sheet: Trailing free cash flow is a robust $518.3 million, and the debt-to-equity ratio is a conservative 0.17. This financial strength provides a cushion against cyclicality and funds growth without excessive leverage.
- Attractive Forward Valuation: The forward P/E of 14.32x is significantly lower than the trailing P/E of 25.59x, implying the market expects a substantial earnings recovery. This forward multiple is more reasonable for an industrial/hardware company.
- Powerful Long-Term Technical Uptrend: The stock is up 132.37% over the past year and is currently trading at 94% of its 52-week high ($185.29). This sustained momentum suggests strong underlying investor conviction in the company's trajectory.
Bearish
- Severe Margin Compression: Q1 2026 gross margin collapsed to 7.56% from 8.87% YoY, and net margin fell to 1.55% from 3.36% in Q3 2025. This indicates the company is struggling to translate massive revenue growth into profits, a core risk in the EMS industry.
- Extreme Revenue Volatility: Q1 2026 revenue of $3.19B followed Q4 2025 revenue of only $2.10B, indicating severe quarter-to-quarter lumpiness. This project-based revenue model creates earnings uncertainty and makes forecasting difficult.
- Elevated Trailing Valuation: A trailing P/E of 25.59x is high for a low-margin contract manufacturer and sits in the upper half of its historical range (8x-42x). This suggests the market has priced in optimistic growth expectations, leaving little room for error.
- Limited Analyst Coverage & High Volatility: Only one analyst provides estimates, leading to poor price discovery. The stock has a 32.69% max drawdown and a beta of 1.05, indicating it is prone to sharp, company-specific swings, increasing investment risk.
SANM Technical Analysis
The stock is in a sustained long-term uptrend but has experienced significant volatility and a recent sharp correction. Over the past year, the price has surged 132.37%, yet the current price of $174.09 sits at approximately 94% of its 52-week high of $185.29, indicating the stock is trading near the top of its range but has retreated from its peak. This positioning near highs suggests persistent momentum but also raises questions about overextension, especially given the recent pullback from the January highs. Recent momentum shows a stark divergence from the powerful yearly trend. While the stock is up 39.24% over the past month, it is down -1.89% over the past three months. This indicates the strong one-month rally is a recovery from a deeper correction that occurred in February and March, where the price fell from over $180 to near $123. The positive one-month relative strength of 31.88% versus the SPY suggests this rebound has strong stock-specific drivers. Key technical levels are clearly defined by the 52-week high of $185.29 as immediate resistance and the 52-week low of $71.84 as major support. A decisive breakout above the $185 resistance would signal a resumption of the primary bull trend, while a failure and reversal could see the stock test lower support levels established during the March sell-off. With a beta of 1.05, the stock's volatility is only marginally higher than the broader market, but the price history shows it is prone to sharp, company-specific moves, as evidenced by the 32.69% maximum drawdown.
Beta
1.05
1.05x market volatility
Max Drawdown
-32.7%
Largest decline past year
52-Week Range
$75-$194
Price range past year
Annual Return
+139.4%
Cumulative gain past year
| Period | SANM Return | S&P 500 |
|---|---|---|
| 1m | +38.7% | +8.7% |
| 3m | +8.1% | +3.6% |
| 6m | +43.6% | +5.4% |
| 1y | +139.4% | +30.6% |
| ytd | +20.6% | +4.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SANM Fundamental Analysis
Sanmina's revenue trajectory shows explosive growth in the most recent quarter, though underlying trends indicate some volatility. For Q1 2026 (ending Dec 27, 2025), revenue surged to $3.19 billion, representing a massive 58.98% year-over-year increase. However, this follows a quarter (Q4 2025) where revenue was only $2.10 billion, indicating significant quarter-to-quarter lumpiness. Segment data shows the Integrated Manufacturing Solutions (IMS) segment, contributing $2.78 billion, is the primary growth driver, vastly overshadowing the CPS segment's $413 million. This growth implies strong end-market demand but also highlights customer concentration and project-based revenue risks. Profitability is present but margins are thin and have compressed notably in the latest quarter. Net income for Q1 2026 was $49.3 million, yielding a net margin of 1.55%. This is a decline from the 3.36% net margin reported in Q3 2025. Gross margin for the latest quarter was 7.56%, a significant drop from the 8.87% gross margin in the year-ago Q1 2025. The operating margin of 3.69% also contracted from 4.42% a year prior. These figures illustrate the company's struggle to maintain profitability amidst rapid top-line expansion, which is characteristic of the low-margin EMS industry. The balance sheet is healthy with moderate leverage and strong cash generation. The debt-to-equity ratio is a conservative 0.17, indicating minimal financial risk. The company's current ratio is a solid 1.72, demonstrating good short-term liquidity. Most importantly, trailing twelve-month free cash flow is a robust $518.3 million. This strong cash generation, coupled with an ROE of 10.45%, shows the company is funding its operations internally and creating shareholder value, providing a cushion against the cyclical nature of its business.
Quarterly Revenue
$3.2B
2025-12
Revenue YoY Growth
+0.58%
YoY Comparison
Gross Margin
+0.07%
Latest Quarter
Free Cash Flow
$518338000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SANM Overvalued?
Given that Net Income is positive ($49.3M in the latest quarter), the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 25.59x, while the forward PE is significantly lower at 14.32x. This substantial gap implies the market expects a meaningful recovery in earnings over the next twelve months, aligning with analyst EPS estimates averaging $12.78. Compared to industry averages, Sanmina's valuation presents a mixed picture. Its trailing PE of 25.59x is elevated relative to typical industrial/hardware peers, which often trade in the mid-teens. However, its Price-to-Sales ratio of 0.77x and EV-to-Sales of 1.11x are more modest, reflecting the company's low net margin profile. The PEG ratio of 1.83 suggests the stock is fairly valued relative to its expected earnings growth, neither deeply discounted nor excessively priced for growth. Historically, the stock's current trailing PE of 25.59x sits above its own multi-year range observed in the historical data, which has typically fluctuated between approximately 8x and 42x. Being in the upper half of its historical band suggests the market is pricing in optimistic expectations, likely tied to the recent explosive revenue growth. Investors are paying a premium compared to the stock's own history, betting that the growth surge is sustainable rather than a one-time event.
PE
25.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 5x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, primarily stemming from severe margin erosion. The Q1 2026 gross margin of 7.56% represents a 131 basis point contraction year-over-year, directly pressuring the already thin net margin of 1.55%. Furthermore, revenue exhibits extreme volatility, jumping 52% sequentially from Q4 to Q1, which indicates heavy dependence on a few large, lumpy customer projects. While the balance sheet is strong (D/E of 0.17), the business model inherently carries high operating leverage and sensitivity to input cost inflation, which could further squeeze profits if revenue growth normalizes. Market & Competitive Risks include valuation compression, given the stock's trailing P/E of 25.6x is elevated for its sector and its own history. As a contract manufacturer in the competitive EMS industry, Sanmina has little pricing power, making sustained margin expansion difficult. The stock's beta of 1.05 suggests market-correlated moves, but its 32.7% max drawdown reveals higher idiosyncratic risk, likely tied to earnings volatility. A sector rotation away from industrials or a macro slowdown in its key defense and industrial markets could disproportionately impact sentiment and multiples. Worst-Case Scenario involves a combination of order cancellations from major customers, continued input cost pressure, and a broader market downturn. This could lead to a rapid deceleration from the 59% growth rate, exacerbating margin pressures and triggering multiple compression. The realistic downside could see the stock re-test support levels from its recent sharp correction, potentially falling towards the $123 area seen in March 2026, representing a decline of approximately -29% from the current price of $174. A breach of that level could see a move toward the 52-week low of $71.84 in a catastrophic scenario, though that seems less probable given improved fundamentals.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Gross margin fell to 7.56% in Q1 2026, threatening already thin net income. 2) Revenue Volatility Risk: Revenue jumped 52% sequentially, indicating a lumpy, project-based business prone to sharp swings. 3) Valuation Risk: The trailing P/E of 25.6x is high and could compress if growth slows. 4) Liquidity & Coverage Risk: With only one analyst providing estimates, the stock suffers from poor price discovery and can experience sharp, news-driven moves, as evidenced by its 32.7% max drawdown.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $160 and $185, assuming revenue growth normalizes and margins stabilize. The Bull Case (30% probability) targets $185 to $220 on successful margin improvement and sustained growth. The Bear Case (20% probability) warns of a drop to $123-$140 if margins worsen and growth stalls. The base case is most likely, anchored by the analyst's $12.78 EPS estimate and the current forward P/E, but the wide range reflects high uncertainty.
SANM's valuation is dichotomous. On a trailing basis, a P/E of 25.6x appears overvalued for a low-margin contract manufacturer and is in the upper half of its own historical range. On a forward basis, a P/E of 14.3x appears more reasonable or even undervalued if the company hits its $12.78 EPS target. The market is currently paying a premium for past growth but a discount to expected future earnings, implying it expects a significant profit recovery. The modest Price-to-Sales ratio of 0.77x provides a valuation floor.
SANM presents a high-risk, high-reward proposition. For investors comfortable with volatility, the 59% revenue growth and reasonable forward P/E of 14.3x could be attractive. However, the severe margin compression and project-based revenue model introduce significant uncertainty. It may be a good buy for aggressive growth investors who believe margins will recover, but it is not suitable for conservative or income-focused portfolios. The lack of analyst coverage further necessitates thorough independent due diligence.
SANM is more suitable for a medium- to long-term investment horizon of 2-3 years, allowing time for its margin recovery thesis to play out. Its high volatility (beta 1.05, 32.7% drawdown) and lack of dividend make it a poor fit for short-term trading or income investors. The cyclical nature of its business and dependence on multi-year manufacturing contracts also align with a longer view. Investors should be prepared to hold through significant price swings.
